ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 103 filers reported holding ALBIREO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $51,000 | +410.0% | 2,397 | +398.3% | 0.00% | – |
| Q3 2022 | $10,000 | +233.3% | 481 | +270.0% | 0.00% | – |
| Q2 2022 | $3,000 | -90.3% | 130 | -87.5% | 0.00% | – |
| Q1 2022 | $31,000 | -64.4% | 1,036 | -72.4% | 0.00% | – |
| Q4 2021 | $87,000 | +93.3% | 3,750 | +159.5% | 0.00% | – |
| Q3 2021 | $45,000 | 0.0% | 1,445 | +15.1% | 0.00% | – |
| Q2 2021 | $45,000 | +9.8% | 1,255 | +8.9% | 0.00% | – |
| Q1 2021 | $41,000 | +2.5% | 1,152 | +8.5% | 0.00% | – |
| Q4 2020 | $40,000 | +135.3% | 1,062 | +109.5% | 0.00% | – |
| Q3 2020 | $17,000 | 0.0% | 507 | -19.4% | 0.00% | – |
| Q2 2020 | $17,000 | +466.7% | 629 | +288.3% | 0.00% | – |
| Q1 2020 | $3,000 | -83.3% | 162 | -75.9% | 0.00% | – |
| Q4 2019 | $18,000 | +800.0% | 672 | +572.0% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -77.8% | 100 | -63.4% | 0.00% | – |
| Q3 2018 | $9,000 | +28.6% | 273 | +54.2% | 0.00% | – |
| Q2 2018 | $7,000 | +133.3% | 177 | +77.0% | 0.00% | – |
| Q1 2018 | $3,000 | – | 100 | +900.0% | 0.00% | – |
| Q4 2017 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 174,791 | $6,556,000 | 3.03% |
| Sio Capital Management, LLC | 354,210 | $13,286,000 | 2.72% |
| Birchview Capital, LP | 92,000 | $3,451,000 | 1.99% |
| Chicago Capital, LLC | 618,263 | $23,191,000 | 1.04% |
| Perceptive Advisors | 2,360,139 | $88,529,000 | 0.95% |
| Endurant Capital Management LP | 42,292 | $1,586,000 | 0.57% |
| Artal Group S.A. | 700,000 | $26,257,000 | 0.56% |
| Cormorant Asset Management, LP | 500,000 | $18,755,000 | 0.45% |
| Samsara BioCapital, LLC | 100,000 | $3,751,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 257,372 | $9,654,000 | 0.34% |